Brian McGovern is a partner at Archer specializing in the practice of corporate law, providing representation to both for-profit and non-profit entities and their principals in a variety of matters. Brian’s practice includes entity formation and dissolution, asset and stock transactions, mergers and acquisitions, restructurings, joint ventures, corporate governance, financing, non-profit and charitable trust tax exemption, licensing, and public contracting.Brian provides advice to clients in both traditional and emerging industries. He is an active member of Archer’s multidisciplinary Cannabis Practice Group, where he lends his corporate and regulatory experience to advise businesses of all sizes on the various rules and regulations involved in this new, and constantly evolving, industry. In the short time that this industry has existed in our region, Brian has worked with a wide variety of clients, including medical cannabis entities who were seeking (and were ultimately successful) in obtaining state licenses, CBD retailers, and cannabis and hemp laboratory testing operations.Brian received his Bachelors of Arts in Political Science from Temple University, followed by his law degree from Rutgers School of Law – Camden. While attending Rutgers, Brian was a Fellow at the Eagleton Institute of Politics and Government. Brian has been recognized as an “Awesome Attorney for Corporate Law by South Jersey Magazine.Recent successes:1. Successfully advised international healthcare client on a $1 billion reorganization. Results: Client converted from for-profit to non-profit with improved access top financial markets for expansions and acquisition.2. Pioneered sale of a cannabis alternative treatment center, the first transaction of its kind in the State of New Jersey. 3. Navigated clients through the evolving and complex public processes to obtain New Jersey cannabis and hemp permits.4. Guided multiple clients through Paycheck Protection Program compliance, specific to selling their businesses.Specialties: Corporate M&A Transactions including Mergers, Stock/Equity Transactions, and Asset Transactions; Secured Financing; Cannabis and Hemp Regulatory Compliance; Corporate Formation, Dissolution, and Governance; Regulatory Compliance; Due Diligence Review;